期刊文献+

射波刀治疗老年早期肺癌患者的初步临床疗效观察 被引量:7

Preliminary Results for Elderly Patients with Early Lung Cancer Treated with CyberKnife~
下载PDF
导出
摘要 目的:探讨采用射波刀(CyberKnife)立体定向放射治疗技术治疗70岁以上老年早期肺癌患者的有效性和安全性。方法:回顾性分析天津医科大学附属肿瘤医院放疗科2006年11月至2010年9月间34例不能手术的老年早期肺癌患者(T_1N_0M_020例,T_2N_0M_014例),中位年龄78(70~88)岁,18例患者采用肿瘤内植入1~2枚金标的呼吸同步追踪技术(Synchrony),16例患者采用椎体追踪技术(X-Sight)。处方剂量45~60 Cy,中位剂量60 Gy,分3~6次给予。结果:25例病变完全缓解(73.5%),9例部分缓解(26.5%)。中位随访期29(11~59)个月,原发肿瘤局部控制率97.1%,1、2、3年无进展生存率分别为85.3%、81.6%、70.0%,总生存率分别为97.1%、86.6%、80.0%。31例患者(91.1%)出现治疗后的轻度乏力,15例患者(44.1%)发生Ⅰ~Ⅱ级放射性肺炎,未发现Ⅲ级及以上的不良反应。1例患者(2.9%)在经胸腔穿刺植入金标后发生严重气胸,经胸腔闭式引流后缓解。结论:射波刀立体定向放射治疗技术疗效确切,不良反应轻,为无法手术的老年早期肺癌患者的较好选择。 Objective: To evaluate the toxicity and efficacy of CyberKnifeR stereotactic radiotherapy in patients with early lung cancer aged over 70 years. Methods: The data of 34 inoperable elderly patients with early lung cancer ( 20 with T1 and 14 with T2 tu- mors ) from November 2006 to September 2010 were retrospectively reviewed. Among them, 18 were treated with the SynchronyR Re- spiratory Tracking System, which requires the implantation of 1-2 gold markers. The other 16 patients were treated with the X-sight~ technology. A total dose of 45-60 Gy ( median of 60 Gy ) was delivered in 3-6 fractions. Results: Complete response was achieved in 25 of the 34 patients ( 73.5% ), and partial response was achieved in the other 9 ( 26.7% ). At a median follow-up of 29 months, the pri- mary tumor control rate was 97.1%. The one-, two-, and three-year disease-free survival rates were 85.3%, 81.6%, and 70%, respective- ly. The one-, two-, and three-year overall survival rates were 97.1%, 86.6%, and 80%, respectively. Slight fatigue was reported in 31 of the 34 patients ( 91.1% ). Grades I and II radiation pneumonitis were observed in 15 of the 34 patients ( 44.1% ). Grade III radiation pneumonitis was not observed. Pneumothorax requiring tube thoracostomy occurred in one patient ( 2.9% ) following CT-guided fidu- cial placement. Conclusion: CyberKnife~ stereotactic radiotherapy is an effective therapeutic modality for elderly patients with early lung cancer. This therapy can provide a high local-control rate for primary tumors and has minimal toxicity.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第15期1119-1122,共4页 Chinese Journal of Clinical Oncology
关键词 老年 早期肺癌 立体定向放射治疗 射波刀 Elderly patient Early lung cancer Stereotactic radiotherapy CyberKnifeR
  • 相关文献

参考文献10

  • 1Boffa DJ. The revised stage classification system for primary lung cancer[J]. Clin Chest Med, 2011, 32(4):741-748.
  • 2Haasbeek CJ, Senan S, Smit EF, et al. Critical review of nonsurgical treatment options for stage I non-small cell lung cancer[J]. Oncolo- gist, 2008, 13(3): 309-319.
  • 3李高峰,李明昱,高鸿,修霞,肖素华,刘明远.70岁及以上早期非小细胞肺癌患者立体定向放射治疗的临床研究[J].中华老年医学杂志,2003,22(8):460-462. 被引量:13
  • 4Kilby W, Dooley JR, Kuduvalli G, et al. The CyberKnife Robotic Radiosurgery System in 2010[J]. Technol Cancer Res Treat, 2010, 9 (5) : 433-452.
  • 5Whitson BA, Groth SS, Duval SJ, et al. Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assist- edthoracoscopic surgery versus thoracotomy approaches to lobecto- my[J]. Ann Thorac Surg, 2008, 86(6): 2008-2016.
  • 6Rowell NP, Williams CJ. Radical radiotherapy for stage Ⅰ/Ⅱ non-small cell lung cancer in patients not sufficiently fit for orde- clining surgery (medicaUy inoperable): a systematic review[J]. Tho- rax, 2001, 56(8): 628-638.
  • 7Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clini- cal outcomes in 245 subjects in a Japanese multiinstitutional study [J]. Cancer, 2004, 101(7): 1623-1631.
  • 8Haasbeek CJ, Lagerwaard FJ, Antonisse ME,et al. Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after ste- reotactic radiotherapy[J]. Cancer, 2010, 116(2): 406-414.
  • 9Palma D, Lagerwaard F, Rodrigues G, et al. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotacticradiotherapy outcomes and systematic review[J]. Int j Radiat Oncol Biol Phys, 2012, 82(3): 1149-1156.
  • 10Anantham D, Fdler-Kopman D, Shanmugham LN, et al. Electro- magnetic navigation bronchoscopy-gnided fiducial placement for robotic stereotacticradiosurgery of lung tumors: a feasibility study[J]. Chest, 2007, 132(3): 930-935.

二级参考文献6

  • 1Emami B,Graham MV. Lung. In: Perez CA, Brady LW, eds.Principles and practice of radiation oncology, 3rd ed.Philadelphia: Lippincott-Raven Publishers,1998. 1181 -1220.
  • 2Noordijk EM,Poest-Clement E, Hermans J, et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol, 1988,13 : 83-89.
  • 3Kuriyama KH, Komiyama T, Tanaka S, et al. Clinical use of stereotactic 3-D conformal multiple dynamic arc radiotherapy forstage I non-small cell lung cancer using a accelerator combined with self-moving CT scanner and patientrs self-breath and beamcontrol technique. Int J Radiat Oncol Biol Phys, 2002,54 : 198.
  • 4Uematsu M, Shioda A, Tahara K, et al. Focal, high-dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer, 1998,82:1062-1068.
  • 5Nagata Y, Negoro Y, Aoki T, et al. Clinical Outcomes of 3-D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys, 2002,52: 1041-1046.
  • 6张红星.放射治疗早期非小细胞肺癌[J].中国放射肿瘤学,1988,2(2):21-21.

共引文献12

同被引文献68

  • 1朱向帜,王绿化,欧广飞,周宗玫,陈东福,肖泽芬,冯勤付,张红星,汪楣,殷蔚伯.三维适形放射治疗局部晚期非小细胞肺癌预后因素分析[J].中华肿瘤杂志,2007,29(10):748-753. 被引量:23
  • 2Bradley J. A review of radiation dose escalation trials for non- small cell lung cancer within the radiation therapy ontology group[J]. Semis Oncol, 2005, 32(2 Suppl 3):111-113.
  • 3Jemal A, Siegel R, Ward E, et al. Cancer states[J]. CA Can- cer J olin, 2009, 59:225-249.
  • 4Zhao L, West BT, Hayman JA, et al. High radiation dose in patients with medically inoperable early- stage non-small cell lung cancer [J]. Int J Radiate Oncol Biol Phys, 2007, 68 (1):103-110.
  • 5Verstegen NE, Lagewaard F J, Senan S. Development in ear- ly- stage NSCLC: advances in radiotherapy[J]. Annals of on- tology, 2012, 23(Suppl 10):46-51.
  • 6Onishi H, Araki T. Stereotactic body radiation therapy for stage i non-small-cell lung cancer: a historical overview of clinical studies[J]. Jpn J Clin Oncol, 2013, 43(4):345-350.
  • 7Samuels MA, Kandula 5, Tulay KL, et al. $tereotactic body radiation therapy in patients with stage I non-small-cell hmg cancer 75 years aiad older: retrospective results flom a multieenter consortium[J]. Clinical Lung Cancer, 2013, 14(4): 446-451.
  • 8Haasbeek C J, Lagerwaard F J, Antonisse ME, et al. Stage I nonsmall cell lung cancer in patients aged/>75 years: out- comes after stereotactic radiotherapy[J]. Cancer, 2010, 116 (2):406-414.
  • 9Onishi H, Shirato H, Nagata Y, et al. Stereotaetie body radio- therapy(SBRT) for operable stage I non-small-cell lung can- cer: can SBRT be comparable to surgery[J].? Int J Radiate Oncol Biol Phys, 2011, 81:1352-1358.
  • 10梁军,李玉,柴广金.图像引导技术与肝胆胰肿瘤放射治疗[M].北京:北京科学技术出版社,2009:86.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部